1. Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999; 340(2): 115-126.
2. Beutler BA. Cerami A. Recombinanat interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 1985; 135(6): 3969-3971.
3. Simon AD, Yazdani Sh, Wang W, Schwartz A, Rabbani LE. Circulating levels of IL-1b, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolys 2000; 9(3): 217-222.
4. Newman P, Kakkar VV, Kance SM. Modulation of endothelin receptor _expression in human vascular smooth muscle cells by interleukin-1b. FEBS Lett 1995; 363(1-2): 161-164.
5. Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K. Nitric oxide attenuates adhesion molecule _expression in human endothelial cells. Cytokine 1996; 8(11): 817-821.
6. Hanson GK. Immune Mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21(12): 1876-1890.
7. Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE. Genomic organization of the interleukin-1 locus. Genomics 2002; 9(1-2): 726-732.
8. Konenkov VI, Smolnicova MV. Structure and functional importance of allelic polymorphism of human cytokine genes and their receptors. Med Immunol 2003; 5(1-2): 11-28.
9. Pociot F, Molving J, Wogensen L. Taq 1 polymorphism in the human interleukin-1b gene correlates with IL-1b secretion in vitro. Eur J Clin Invest 1992; 22(6): 96-402.
10. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
11. Bioque G, Crusius JBA, Koutroubakis I. Allelic polymorphism in IL-1b and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102(2): 379-383.
12. Roff PA, Bentzen P. The statistical analysis of mitochondrial DNA polymorphisms: Chi 2 and the problem of small samples. Mol Biol Evol 1989; 6(5): 539-545.
13. Zhivotovsky LA. Population Biometrics. Moscow: Nauka, 1991.
14. Schlesseman J. Case-Control Studies: Design, Conduct, Analysis. New York: Oxford University Press, 1982.
15. Hsien YY, Chang CC, Tsai FJ, Wu JY, Shi YR, Tsai HD, Tsai CH. Polymorphisms for interleukin-1b (IL-1b)-511 promoter, IL-1b exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis. J Ass Reprod Gen 2001; 18(9): 506-511.
16. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001; 48(3): 397-402.
17. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S, Uchikoshi T. Genetic polymorphisms of interleukin-1b in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 2000; 95(5): 1305-1311.
18. Constantini PK, Wawrzynowicz-Syczewska M, Clare M, Boron-Kaczmarska A McFarlane IG, Gramp ME, Donaldson RT. Interleukin-1, interleukin-10 and tumor necrosis factor-a gene polymorphism in hepatitis C virus infection: an investigation of relationships with spontaneous viral clearance and response to a-interferon therapy. Liver 2002; 22(5): 404-412.
19. Chen WC, Wu HC, Chen HY, Wu MC, Hsu CD, Tsai FJ. Interleukin-1b gene and receptor antagonist gene polymorphism in patients with calcium oxalate stones. Urol Res 2001; 29(5): 321-324.
20. Hefler LA, Tempfer CB, Gregg AR. Polymorphisms within the interleukin-1b gene cluster and preeclampsia. Obstet Gynecol 2001; 97(5): 664-668.
21. Francis SE, Camp NJ, Dewberry RMm, Gunn J, Syrris P, Carter ND, Jeffry S, Kaski JC, Cumberland DC, Duff GW, Crossman DC. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999; 99(7): 861-866.
22. Tseng LH, Chen PJ, Lin MT Shau WY, Chaung SM, Martin PJ, Hansen JA. Single nucleotide polymorphism in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1b and IL-1Ra polymorphism in North American Caucasians and Taiwanese Chinese. Tissue Antigens 2001; 57(4): 318-324.
23. Tracey KJ, Cerami A. Metabolic responses to cachectin/TNF: a brief review. Ann N Y Acad Sci USA 1990; 587(1): 325-331.
